Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ – Get Free Report) was the target of a significant decline in short interest in the month of July. As of July 15th, there was short interest totalling 15,200 shares, a decline of 14.1% from the June 30th total of 17,700 shares. Approximately 1.2% of the company’s shares are short sold. Based on an average daily trading volume, of 7,200 shares, the short-interest ratio is presently 2.1 days.
Creative Medical Technology Trading Down 2.5 %
Shares of NASDAQ CELZ traded down $0.09 during trading hours on Tuesday, reaching $3.47. The stock had a trading volume of 3,448 shares, compared to its average volume of 93,671. The firm has a market cap of $4.68 million, a price-to-earnings ratio of -0.93 and a beta of 2.12. The business’s fifty day moving average price is $3.88 and its two-hundred day moving average price is $4.43. Creative Medical Technology has a 52-week low of $2.90 and a 52-week high of $10.28.
Creative Medical Technology (NASDAQ:CELZ – Get Free Report) last posted its earnings results on Friday, May 10th. The company reported ($0.73) earnings per share for the quarter, topping analysts’ consensus estimates of ($1.15) by $0.42. Equities research analysts anticipate that Creative Medical Technology will post -3.29 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Creative Medical Technology
Creative Medical Technology Company Profile
Creative Medical Technology Holdings, Inc, a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease.
Featured Articles
- Five stocks we like better than Creative Medical Technology
- Conference Calls and Individual Investors
- AbbVie Analysts Lead the Stock Higher as Humira Worries Recede
- Are Penny Stocks a Good Fit for Your Portfolio?
- Harley-Davidson Stock Revs Up With Billion Dollar Buyback Program
- What Makes a Stock a Good Dividend Stock?
- Cruise Line Stock Sinks Despite Beating EPS and Raised Guidance
Receive News & Ratings for Creative Medical Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creative Medical Technology and related companies with MarketBeat.com's FREE daily email newsletter.